Landis Rath & Cobb LLP

Delaware

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases10

Challenger50%

Patent Owner50%

NPE50%

lrclaw

lrclaw.com

Practice Areas

BiotechComp. Arch. and SoftwareCommunications

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
10/31/22	Biogen Intl GmbH v. Amneal Pharma LLC 1:17-CV-00823 ( D. DE )	USCA Order Terminating Appeal as to 410 Notice of Appeal (Federal Circuit) filed by Biogen International GmbH, Biogen MA Inc.. USCA Decision: Appeal Dismissed. (mdb) (Entered: 10/31/2022)
09/23/20	Biogen Intl GmbH v. Cipla Ltd 1:17-CV-00851 ( D. DE )	Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # 1 Judgment)(mdb) (Entered: 09/23/2020)
09/22/20	Biogen Intl GmbH v. Cipla Ltd 1:17-CV-00851 ( D. DE )	JUDGMENT in favor of Accord Healthcare Inc., Alkem Laboratories Ltd., Amneal Pharmaceuticals LLC, Cipla Limited, Cipla USA Inc., Graviti Pharmaceuticals Inc., Graviti Pharmaceuticals Pvt. Ltd., Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA Inc., Impax Laboratories LLC, Lupin Atlantis Holdings SA, MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Pharmathen S.A., Prinston Pharmaceutical Inc., S&B Pharma, Inc., Sandoz Inc., Shilpa Medicare Limited, Slayback Pharma India LLP, Slayback Pharma LLC, TWi Pharmaceuticals Inc., TWi Pharmaceuticals USA Inc., TWi Pharmaceuticals USA, Inc., TWi Pharmaceuticals, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Windlas Healthcare Pvt. Ltd., Zydus Pharmaceuticals (USA) Inc. against Biogen International GmbH, Biogen MA Inc. (CASE CLOSED). Signed by Judge Maryellen Noreika on 9/22/2020. (dlw) (Entered: 09/22/2020) JUDGMENT in favor of Accord Healthcare Inc., Alkem Laboratories Ltd., Amneal Pharmaceuticals LLC, Cipla Limited, Cipla USA Inc., Graviti Pharmaceuticals Inc., Graviti Pharmaceuticals Pvt. Ltd., Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA Inc., Impax Laboratories LLC, Lupin Atlantis Holdings SA, MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Pharmathen S.A., Prinston Pharmaceutical Inc., S&B Pharma, Inc., Sandoz Inc., Shilpa Medicare Limited, Slayback Pharma India LLP, Slayback Pharma LLC, TWi Pharmaceuticals Inc., TWi Pharmaceuticals USA Inc., TWi Pharmaceuticals USA, Inc., TWi Pharmaceuticals, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Windlas Healthcare Pvt. Ltd., Zydus Pharmaceuticals (USA) Inc. against Biogen International GmbH, Biogen MA Inc. (CASE CLOSED). Signed by Judge Maryellen Noreika on 9/22/2020. (dlw) (Entered: 09/22/2020)
02/07/20	Biogen Intl GmbH v. Cipla Ltd 1:17-CV-00851 ( D. DE )	NOTICE OF SUBSTITUTION OF COUNSEL re Cipla Limited, Cipla USA Inc.: Entry of appearance of attorney Jennifer L. Cree. Attorney James S. Green Jr. terminated. (Cree, Jennifer) (Entered: 02/07/2020)
01/31/18	Biogen Intl GmbH v. Cipla Ltd 1:17-CV-00851 ( D. DE )	PROPOSED ORDER (Proposed Scheduling Order) by Biogen International GmbH, Biogen MA Inc.. (Balick, Steven) (Entered: 01/31/2018)
01/31/18	Biogen Intl GmbH v. Cipla Ltd 1:17-CV-00851 ( D. DE )	Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding the Parties Proposed Scheduling Order. (Balick, Steven) (Entered: 01/31/2018)
01/23/18	Biogen Intl GmbH v. Cipla Ltd 1:17-CV-00851 ( D. DE )	Official Transcript of Scheduling Telephone Conference held on January 17, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone No. (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/13/2018. Redacted Transcript Deadline set for 2/23/2018. Release of Transcript Restriction set for 4/23/2018.(bpg) (Entered: 01/23/2018) Official Transcript of Scheduling Telephone Conference held on January 17, 2018 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, Telephone No. (302) 573-6360. Transcript may be viewed at the court public terminal or purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/13/2018. Redacted Transcript Deadline set for 2/23/2018. Release of Transcript Restriction set for 4/23/2018.(bpg) (Entered: 01/23/2018)
05/02/16	Vanda Pharma Inc v. Lupin Ltd 1:15-CV-01073 ( D. DE )	NOTICE of Withdrawal of Counsel by Vanda Pharmaceuticals Inc. (Jacobs, Karen) (Entered: 05/02/2016)
05/02/16	Vanda Pharma Inc v. Lupin Ltd 1:15-CV-01073 ( D. DE )	Joint STIPULATION TO EXTEND TIME for the parties to submit a proposed protective order to May 16, 2016 - filed by Vanda Pharmaceuticals Inc.. (Jacobs, Karen) (Entered: 05/02/2016)
04/19/16	Vanda Pharma Inc v. Lupin Ltd 1:15-CV-01073 ( D. DE )	NOTICE OF SERVICE of (1) Vanda Pharmaceuticals Inc.s Disclosures Pursuant to Delaware Default Standard for Discovery including Discovery of Electronically Stored Information and (2) Plaintiff Vanda Pharmaceuticals Inc.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Vanda Pharmaceuticals Inc..(Townsend, Ethan) (Entered: 04/19/2016)